Abstract
Background Homelessness may result in the breakdown of regular health services, including routine vaccination programmes. A literature review was conducted to describe vaccine-preventable diseases (VPD) other than tuberculosis in homeless populations and to summarize vaccination recommendations in homeless people.
Methods We followed Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We searched peer-reviewed literature published in English, French or Spanish reporting the outbreak of VPD or VPD prevalence in both infant and adult homeless populations published between 1980 and 2020, using PubMed/Medline, SciELO, Google Scholar, and Web of Science databases. Relevant information from the studies was charted in Microsoft Excel and results were summarised using a descriptive analytical method.
Results Seventy-five articles were included. A high prevalence of past HBV and HAV infections were observed through serosurveys, mostly in high income countries or high-middle income countries (USA, Canada, France, Iran or Brazil). Nine outbreaks of HAV infection were also reported, with lethality rates ranging from 0-4.8%. The studies discussed numerous risk factors positively associated with HBV infection, including older age, homosexual or bisexual practice, injected drug use (IDU), and, with HAV infection including IDU, having sexual partner(s) with a history of unspecified hepatitis, insertive anal penetration, or originating from a country with a high prevalence of anti-HAV antibody. Eleven outbreaks of pneumococcal infection affecting homeless persons were reported in Canada and USA, with lethality rates from 0-15.6%. Five diphtheria outbreaks were reported. Vaccination status was rarely documented in these studies.
Conclusions The literature suggests that homeless populations generally experience a higher VPD burden and lower immunisation rates. The findings suggest the need for a national vaccination programme and planning for delivering vaccines in this population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No Funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Not applicable
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Not applicable
